Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Advanced Manufacturing Technologies Shift Outside the Box

April 03, 2021

Intensified and distributed manufacturing approaches create flexible, local capacity.

Supply Chain Challenges Creating Hurdles to COVID-19 Vaccine Production

April 02, 2021

The availability of materials is a critical factor when it comes to vaccine capacity.

SGS Facilitates Phase I Study of ImmTOR in Gene Therapy

March 30, 2021

SGS is supporting Selecta Biosciences and Asklepios BioPharmaceutical with the Phase I dose-escalation trial of SEL-3999, an AAV8 vector capsid containing no transgene with ImmTOR.

Celonic Group to Manufacture CureVac’s mRNA COVID Vaccine Candidate

March 30, 2021

Celonic will manufacture CvnCoV at its facility in Germany.

Stelis Concludes Fundraise Worth $195 Million

March 25, 2021

Stelis Biopharma has closed its Series B and Series C fundraise for US $195 million, which will be used to progress the company’s growth initiatives and help scale its business.

Expediting IND Submission

March 18, 2021

An integrated CMC provider can help smaller companies to streamline development timelines and reduce project management complexity when compared with multi-provider models.

Digital Inventory Platform Improves Data Access

March 03, 2021

A digital system makes real-time inventory, production, distribution, and shipping information readily accessible.

Demonstrating the Value of Collaboration

March 02, 2021

The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.

Necessity Drives Just-in-Time Approaches to Clinical Trials Supply

March 02, 2021

The COVID-19 pandemic is pushing more companies to adopt just-in-time practices, but success demands careful upfront risk assessment and planning.

Meeting CGT Demand

March 02, 2021

More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.